↓ Skip to main content

Methylprednisolone or dexamethasone, which one is superior corticosteroid in the treatment of hospitalized COVID-19 patients: a triple-blinded randomized controlled trial

Overview of attention for article published in BMC Infectious Diseases, April 2021
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • Among the highest-scoring outputs from this source (#36 of 8,658)
  • High Attention Score compared to outputs of the same age (99th percentile)
  • High Attention Score compared to outputs of the same age and source (98th percentile)

Mentioned by

news
4 news outlets
twitter
480 X users
facebook
2 Facebook pages

Citations

dimensions_citation
167 Dimensions

Readers on

mendeley
333 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Methylprednisolone or dexamethasone, which one is superior corticosteroid in the treatment of hospitalized COVID-19 patients: a triple-blinded randomized controlled trial
Published in
BMC Infectious Diseases, April 2021
DOI 10.1186/s12879-021-06045-3
Pubmed ID
Authors

Keivan Ranjbar, Mohsen Moghadami, Alireza Mirahmadizadeh, Mohammad Javad Fallahi, Vahid Khaloo, Reza Shahriarirad, Amirhossein Erfani, Zohre Khodamoradi, Mohammad Hasan Gholampoor Saadi

X Demographics

X Demographics

The data shown below were collected from the profiles of 480 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 333 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 333 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 46 14%
Student > Master 32 10%
Researcher 22 7%
Other 19 6%
Student > Postgraduate 16 5%
Other 60 18%
Unknown 138 41%
Readers by discipline Count As %
Medicine and Dentistry 108 32%
Pharmacology, Toxicology and Pharmaceutical Science 20 6%
Nursing and Health Professions 15 5%
Biochemistry, Genetics and Molecular Biology 10 3%
Immunology and Microbiology 7 2%
Other 24 7%
Unknown 149 45%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 335. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 23 February 2024.
All research outputs
#99,556
of 25,589,756 outputs
Outputs from BMC Infectious Diseases
#36
of 8,658 outputs
Outputs of similar age
#3,172
of 456,526 outputs
Outputs of similar age from BMC Infectious Diseases
#4
of 196 outputs
Altmetric has tracked 25,589,756 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 99th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 8,658 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 10.7. This one has done particularly well, scoring higher than 99% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 456,526 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 99% of its contemporaries.
We're also able to compare this research output to 196 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 98% of its contemporaries.